Bridgefront Capital’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13,206
Closed -$324K – 781
2026
Q1
$324K Buy
+13,206
New +$313K 0.08% 372
2025
Q4
– Sell
-7,875
Closed -$223K – 822
2025
Q3
$223K Buy
+7,875
New +$213K 0.07% 491

Other funds holding ASTH

Bridgefront Capital's ASTH Position: Q2 2026 in Review

Bridgefront Capital sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 13,206 shares — an estimated $324K sold.

Bridgefront Capital first reported a position in ASTH in Q3 2025 and held it in 2 quarters. The position peaked at $324K in Q1 2026. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Bridgefront Capital reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 13,206 Astrana Health shares in Q2 2026, an estimated $324K.
  • Bridgefront Capital first reported a position in Astrana Health in Q3 2025 and held it in 2 quarters.
  • Bridgefront Capital's Astrana Health position peaked at $324K in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.